Design and Evaluation Cefaclor Microspheres for Bioavailability Enhancement
DOI:
https://doi.org/10.37591/rrjodfdp.v6i3.600Abstract
This study attempted to formulate microspheres for oral administration of Cefaclor by using different polymers like Hydroxypropyl methylcellulose (HPMC) K4M, (HPMC) K15M and Ethylcellulose (EC) which increases the gastric residence time and thereby the bioavailability. Solvent evaporation method was found to be the best due to its ease of fabrication without compromising the activity of the drug. Cefaclor is a second-generation cephalosporin antibiotic used to treat certain ear, lung, skin, throat and urinary tract infections and also infections caused by bacteria such as pneumonia, septicaemia, meningitis and peritonitis. Fourier Transform Infrared spectroscopy, Differential Scanning Colorimetry and X-ray diffraction study showed that and EC, HPMC K4 and HPMC K15 are compatible. Prepared Cefaclor microspheres by solvent evaporation technique were spherical in shape and size in 116‑130 um. The preparation F1 (72.6%) showed highest entrapment efficiency. The formulations F1 and F4 showed the highest dissolution rate of 76% and the lowest dissolution rate was for F2 with 67.4% at the end of 24 h. In vitro drug release kinetics for preparations, F1-F6 followed zero-order kinetics and the mechanism of drug release was diffusion-controlled. Cefaclor microspheres can be used in sustaining the action of Cefaclor and thereby enhancing its bioavailability.
Keywords: Calibration curve, Cefaclor, drug, electron microscopy, FTIR, HPMC (Hydroxypropyl methylcellulose), microspheres
Cite this Article
Amutha Gnana Arasi M.A., Vikram Pemula, Gopal Rao M. Design and Evaluation Cefaclor Microspheres for Bioavailability Enhancement. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2019; 6(3): 39–48p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |